Ramesh Mullangi
Thermo Fisher Scientific (Norway)(NO)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Analytical Methods in Pharmaceuticals, Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectives(2009)173 cited
- → Analysis of five HMG‐CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies(2005)100 cited
- → A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders(2018)98 cited
- → Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC–MS/MS with electrospray ionization: Assay development, validation and application to a clinical study(2005)85 cited
- → Simultaneous estimation of six anti‐diabetic drugs—glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay(2006)85 cited
- → Antidiabetic and hypolipidemic activity of Helicteres isora in animal models(2002)76 cited
- → PLK4: a link between centriole biogenesis and cancer(2017)75 cited
- → Determination of rosuvastatin in rat plasma by HPLC: validation and its application to pharmacokinetic studies(2006)72 cited
- → Emerging role of SETDB1 as a therapeutic target(2017)71 cited
- → Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC‐MS/MS and its application to a human pharmacokinetic study(2010)60 cited